Cargando…
CRISPR Technology: A Jewish Legal Perspective
Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human lon...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622389/ https://www.ncbi.nlm.nih.gov/pubmed/36394501 http://dx.doi.org/10.5041/RMMJ.10487 |
_version_ | 1784821756945498112 |
---|---|
author | Loike, John D. Flaum, Rabbi Tzvi |
author_facet | Loike, John D. Flaum, Rabbi Tzvi |
author_sort | Loike, John D. |
collection | PubMed |
description | Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human longevity, in animal breeding, and in plant science. However, there are many ethical challenges that emerge from CRISPR technology. This article discusses several positions that relate to these ethical challenges from a Jewish legal perspective. In addition, we present several other applications of CRISPR technology that lack a defined Jewish legal precedent and require rabbinical scholars to address and resolve them in the future. |
format | Online Article Text |
id | pubmed-9622389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Rambam Health Care Campus |
record_format | MEDLINE/PubMed |
spelling | pubmed-96223892022-11-04 CRISPR Technology: A Jewish Legal Perspective Loike, John D. Flaum, Rabbi Tzvi Rambam Maimonides Med J Perspective Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human longevity, in animal breeding, and in plant science. However, there are many ethical challenges that emerge from CRISPR technology. This article discusses several positions that relate to these ethical challenges from a Jewish legal perspective. In addition, we present several other applications of CRISPR technology that lack a defined Jewish legal precedent and require rabbinical scholars to address and resolve them in the future. Rambam Health Care Campus 2022-10-27 /pmc/articles/PMC9622389/ /pubmed/36394501 http://dx.doi.org/10.5041/RMMJ.10487 Text en Copyright: © 2022 Loike and Flaum https://creativecommons.org/licenses/by/3.0/This is an open-access article. All its content, except where otherwise noted, is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspective Loike, John D. Flaum, Rabbi Tzvi CRISPR Technology: A Jewish Legal Perspective |
title | CRISPR Technology: A Jewish Legal Perspective |
title_full | CRISPR Technology: A Jewish Legal Perspective |
title_fullStr | CRISPR Technology: A Jewish Legal Perspective |
title_full_unstemmed | CRISPR Technology: A Jewish Legal Perspective |
title_short | CRISPR Technology: A Jewish Legal Perspective |
title_sort | crispr technology: a jewish legal perspective |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622389/ https://www.ncbi.nlm.nih.gov/pubmed/36394501 http://dx.doi.org/10.5041/RMMJ.10487 |
work_keys_str_mv | AT loikejohnd crisprtechnologyajewishlegalperspective AT flaumrabbitzvi crisprtechnologyajewishlegalperspective |